Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses.
Most monoclonal antibodies (mAbs) to the influenza A virus hemagglutinin (HA) head domain exhibit very limited breadth of inhibitory activity due to antigenic drift in field strains. However, mAb 1F1, isolated from a 1918 influenza pandemic survivor, inhibits select human H1 viruses (1918, 1943, 194...
Main Authors: | Tshidi Tsibane, Damian C Ekiert, Jens C Krause, Osvaldo Martinez, James E Crowe, Ian A Wilson, Christopher F Basler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Pathogens |
Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1003067&type=printable |
Similar Items
-
Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.
by: Balaji Manicassamy, et al.
Published: (2010-01-01) -
Emerging antigenic variants at the antigenic site Sb in pandemic A(H1N1)2009 influenza virus in Japan detected by a human monoclonal antibody.
by: Mayo Yasugi, et al.
Published: (2013-01-01) -
Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein
by: Lauren A. Ford-Siltz, et al.
Published: (2022-10-01) -
Class 1 major histocompatibility complex antigens on human extra-villous trophoblast.
by: Redman, C, et al.
Published: (1984) -
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.
by: Simmons, C, et al.
Published: (2007)